Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 23, 2013 - Issue 2
Submit an article Journal homepage
664
Views
11
CrossRef citations to date
0
Altmetric
Review

Novel prostaglandin receptor modulators – Part II: EP receptor modulators; a patent review (2002 – 2012)

Daniel FleschInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt/Main, [email protected]
,
Daniel MerkInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt/Main, [email protected]
,
Christina LamersInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt/Main, [email protected]
&
Manfred Schubert-ZsilaveczInstitute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt/Main, [email protected]
Pages 233-267 | Published online: 04 Jan 2013

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sabine Grösch, Ellen Niederberger & Gerd Geisslinger. (2017) Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain. Expert Opinion on Investigational Drugs 26:1, pages 51-61.
Read now

Articles from other publishers (10)

Luying Chen, Ge Yan & Tomohiko Ohwada. (2022) Building on endogenous lipid mediators to design synthetic receptor ligands. European Journal of Medicinal Chemistry 231, pages 114154.
Crossref
Xuqing Zhang, Bin Zhu, Lili Guo, Ivona Bakaj, Matthew Rankin, George Ho, Jack Kauffman, Seunghun P. Lee, Lisa Norquay & Mark Macielag. (2021) Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 47, pages 128172.
Crossref
Debasis Das & Jian Hong. (2021) Prostaglandin E2 Receptor 4 (EP4): A Promising Therapeutic Target for the Treatment of Cancer and Inflammatory Diseases. Current Chemical Biology 15:1, pages 50-68.
Crossref
A. Heeney, AC. Rogers, H. Mohan, F. Mc Dermott, AW. Baird & DC. Winter. (2021) Prostaglandin E2 receptors and their role in gastrointestinal motility – Potential therapeutic targets. Prostaglandins & Other Lipid Mediators 152, pages 106499.
Crossref
Ji Zhang, Eyal Vardy, Eric S. Muise, Tzu-Ming Wang, Richard Visconti, Ashita Vadlamudi, Shirly Pinto & Andrea M. Peier. (2020) Utilizing Designed Receptors Exclusively Activated by Designer Drug Chemogenetic Tools to Identify Beneficial G Protein–Coupled Receptor Signaling for Fibrosis. Journal of Pharmacology and Experimental Therapeutics 375:2, pages 357-366.
Crossref
Ewgenij Proschak, Pascal Heitel, Lena Kalinowsky & Daniel Merk. (2017) Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery. Journal of Medicinal Chemistry 60:13, pages 5235-5266.
Crossref
Anna Cooper, Sameek Singh, Sarah Hook, Joel D. A. Tyndall & Andrea J. Vernall. (2017) Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors. Pharmacological Reviews 69:3, pages 316-353.
Crossref
Tijana Markovič, Žiga Jakopin, Marija Sollner Dolenc & Irena Mlinarič-Raščan. (2017) Structural features of subtype-selective EP receptor modulators. Drug Discovery Today 22:1, pages 57-71.
Crossref
Esther C.Y. Lee, Kentaro Futatsugi, Joel T. Arcari, Kevin Bahnck, Steven B. Coffey, David R. Derksen, Amit S. Kalgutkar, Paula M. Loria & Raman Sharma. (2016) Optimization of amide-based EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 26:11, pages 2670-2675.
Crossref
Jon Sutton, David E. Clark, Christopher Higgs, Marcel J. de Groot, Neil V. Harris, Andrea Taylor, Peter M. Lockey, Karen Maubach, Amanda Woodrooffe, Richard J. Davis, Robert A. Coleman & Kenneth L. Clark. (2014) From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor. Bioorganic & Medicinal Chemistry Letters 24:9, pages 2212-2221.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.